Trial: 201709068

A Pilot Study of Belimumab (Benlysta) for Prevention of Chronic Graft-versus-Host Disease Following Allogeneic Hematopoietic Cell Transplantation

Phase

I

Principal Investigator

Pusic, Iskra

Disease Site

Other Hematopoietic

Learn more about this study at: clinicaltrials.gov